Log in

Relevant bibliographies by topics / Antiinfluenza

Academic literature on the topic 'Antiinfluenza'

Author: Grafiati

Published: 10 December 2022

Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Journal articles
Book chapters

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antiinfluenza.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Antiinfluenza"

1

Covés-Datson, Evelyn M., Steven R. King, Maureen Legendre, Auroni Gupta, Susana M. Chan, Emily Gitlin, Vikram V. Kulkarni, et al. "A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo." Proceedings of the National Academy of Sciences 117, no. 4 (January 13, 2020): 2122–32. http://dx.doi.org/10.1073/pnas.1915152117.

Full text

Abstract:

There is a strong need for a new broad-spectrum antiinfluenza therapeutic, as vaccination and existing treatments are only moderately effective. We previously engineered a lectin, H84T banana lectin (H84T), to retain broad-spectrum activity against multiple influenza strains, including pandemic and avian, while largely eliminating the potentially harmful mitogenicity of the parent compound. The amino acid mutation at position 84 from histidine to threonine minimizes the mitogenicity of the wild-type lectin while maintaining antiinfluenza activity in vitro. We now report that in a lethal mouse model H84T is indeed nonmitogenic, and both early and delayed therapeutic administration of H84T intraperitoneally are highly protective, as is H84T administered subcutaneously. Mechanistically, attachment, which we anticipated to be inhibited by H84T, was only somewhat decreased by the lectin. Instead, H84T is internalized into the late endosomal/lysosomal compartment and inhibits virus–endosome fusion. These studies reveal that H84T is efficacious against influenza virus in vivo, and that the loss of mitogenicity seen previously in tissue culture is also seen in vivo, underscoring the potential utility of H84T as a broad-spectrum antiinfluenza agent.

APA, Harvard, Vancouver, ISO, and other styles

2

DeGoey, David A., Hui-Ju Chen, William J. Flosi, David J. Grampovnik, Clinton M. Yeung, Larry L. Klein, and Dale J. Kempf. "Enantioselective Synthesis of Antiinfluenza Compound A-315675." Journal of Organic Chemistry 67, no. 16 (August 2002): 5445–53. http://dx.doi.org/10.1021/jo0162890.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Traynor, Kate. "Antiinfluenza medication kits need work, FDA advisers conclude." American Journal of Health-System Pharmacy 65, no. 24 (December 15, 2008): 2314–16. http://dx.doi.org/10.2146/news080098.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Sznaidman, Marcos L., Eric A. Meade, Lilia M. Beauchamp, Stuart Russell, and Margaret Tisdale. "The antiinfluenza activity of pyrrolo[2,3-d]pyrimidines." Bioorganic & Medicinal Chemistry Letters 6, no. 5 (March 1996): 565–68. http://dx.doi.org/10.1016/0960-894x(96)00070-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Mokrushina, G. A., S. K. Kotovskaya, G. N. Tyurenkova, V. I. Il'enko, V. G. Platonov, and I. V. Kiseleva. "Synthesis of 2-hydrazinobenzimidazoles and their antiinfluenza activity." Pharmaceutical Chemistry Journal 22, no. 2 (February 1988): 146–50. http://dx.doi.org/10.1007/bf00758445.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Ge, Hu, Yi-Fei Wang, Jun Xu, Qiong Gu, Hai-Bo Liu, Pei-Gen Xiao, Jiaju Zhou, Yanhuai Liu, Zirong Yang, and Hua Su. "ChemInform Abstract: Antiinfluenza Agents from Traditional Chinese Medicine." ChemInform 42, no. 13 (March 3, 2011): no. http://dx.doi.org/10.1002/chin.201113269.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Dyason, Jeffrey C., and Mark von Itzstein. "ChemInform Abstract: Antiinfluenza Virus Drug Design: Sialidase Inhibitors." ChemInform 33, no. 29 (May 20, 2010): no. http://dx.doi.org/10.1002/chin.200229266.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Zhang, Chun Jing, and Hai Tao Yu. "The Signal Pathways of Immune Inflammation Mediated by the Tlr3/Nf-Kappab and Activator Protein-1 in Cells Infected with Influenza A Virus Antagonized by Baicalin." Advanced Materials Research 345 (September 2011): 201–9. http://dx.doi.org/10.4028/www.scientific.net/amr.345.201.

Full text

Abstract:

Baicalin has better anti-inflammatory function, antioxidant function and antiviral activity, but the mechanism of the antiinfluenza viral activity of baicalin has not been revealed.Toll-like Receptor 3 and the signal pathways mediated by TLR3 were affected and controlled by the infections with influenza A virus. We report here the significant activity and part mechanism of baicalin against H3N2 influenza A viruses. Baicalin could well protect the damages of cells caused by influenza A virus, it also could effectively inhibit the production of CPE in cells caused by influenza A virus and the inhibition of cells growth. The mechanism of antiinfluenza virus infection of baicalin may be related with the following aspects: to decrease the transcriptional activity of the oxidative stress sensitive transcription factor NF-kappaB and AP-1 by moderately decrease the higher expression level of TLR3 mRNA and the higher expression level of protein; and to further inhibit the mRNA expression of the downstream target genes IL-1β, IL-8, RANTES and IFN-β thereby alleviate the inflammatory injuries and restore the stability and balance of immune function in vivro.

APA, Harvard, Vancouver, ISO, and other styles

9

Yoo, Jae-Kwang, Carole L. Galligan, Carl Virtanen, and Eleanor N. Fish. "Identification of a novel antigen-presenting cell population modulating antiinfluenza type 2 immunity." Journal of Experimental Medicine 207, no. 7 (June 14, 2010): 1435–51. http://dx.doi.org/10.1084/jem.20091373.

Full text

Abstract:

Antiinfluenza type 2 (T2) immunity contributes to both immunopathology and immunoprotection, yet the underlying mechanisms modulating T2 immunity remain ill defined. We describe a novel mouse antigen (Ag)-presenting cell (APC), designated late-activator APC (LAPC). After pulmonary influenza A (H1N1) virus infection, LAPCs enter the lungs, capture viral Ag, and subsequently migrate to the draining lymph node (DLN) and spleen, with delayed kinetics relative to dendritic cells (DCs). In the DLN, influenza virus–activated LAPCs present Ag and selectively induce T helper type 2 (Th2) effector cell polarization by cell–cell contact–mediated modulation of GATA-3 expression. In adoptive transfer experiments, influenza virus–activated LAPCs augmented Th2 effector T cell responses in the DLN, increased production of circulating antiinfluenza immunoglobulin, and increased levels of T2 cytokines in bronchoalveolar lavage fluid in recipient influenza virus–infected mice. LAPC-recipient mice exhibited exacerbated pulmonary pathology, with delayed viral clearance and enhanced pulmonary eosinophilia. Collectively, our results identify and highlight the importance of LAPCs as immunomodulators of T2 immunity during influenza A virus infection.

APA, Harvard, Vancouver, ISO, and other styles

10

Tuttle, Joel V., Margaret Tisdale, and Thomas A. Krenitsky. "Purine 2'-deoxy-2'-fluororibosides as antiinfluenza virus agents." Journal of Medicinal Chemistry 36, no. 1 (January 1993): 119–25. http://dx.doi.org/10.1021/jm00053a015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Antiinfluenza"

1

Braciale, Vivian Lam. "Generation of CD4+ and CD8+ Antiinfluenza CTL and Assay of In Vitro Cytotoxicity." In Cytotoxic Cells: Recognition, Effector Function, Generation, and Methods, 490–91. Boston, MA: Birkhäuser Boston, 1993. http://dx.doi.org/10.1007/978-1-4684-6814-4_53.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Mondal, Debasis. "Antiinfluenza A Virus Agents." In xPharm: The Comprehensive Pharmacology Reference, 1–2. Elsevier, 2007. http://dx.doi.org/10.1016/b978-008055232-3.61030-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!